A Phase Ib Study of Sovilnesib in Subjects With Ovarian Cancer
Conditions: High Grade Serous Adenocarcinoma of Ovary; Fallopian Tube Cancer; Primary Peritoneal Carcinoma; Chromosomal Instability Interventions: Drug: Sovilnesib Sponsors: Volastra Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Fallopian Tube Cancer | Ovarian Cancer | Ovaries | Research | Serous Carcinoma | Study